Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Comment by PrivateEquity1on Jul 15, 2017 8:14pm
120 Views
Post# 26473542

RE:RE:ISOL Stepping into the $83 Billion Dollar Pain Relief Market

RE:RE:ISOL Stepping into the $83 Billion Dollar Pain Relief Market
In fairness that FDA statement must appear by law on any health supplement where there has not been strong scientific evidence via clinical studies presented.

Studies on CBD and cannabinoids have been severely restricted by law in the US and only since mid 2016 have studies been more openly allowed.  So that will most likely change in time.

Bullboard Posts